Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	422	679	24	34	31	37
Market Cap Growth	2670.20%	2670.20%	-28.27%	10.23%	-17.11%	310.61%
Enterprise Value	39	304	-13	-8	-22	-11
PE Ratio	-	-8.10	-4.59	-3.44	-1.60	-3.84
PB Ratio	0.09	1.78	0.66	0.82	0.61	0.80
P/FCF Ratio	-11.70	-11.70	-4.89	-3.13	-1.65	-4.83
P/OCF Ratio	-11.73	-11.73	-4.89	-3.13	-1.65	-4.84
EV/EBITDA Ratio	-3.70	-3.70	2.43	0.82	1.14	1.17
EV/EBIT Ratio	-3.70	-3.70	2.38	0.81	1.14	1.16
EV/FCF Ratio	-5.24	-5.24	2.54	0.73	1.17	1.46
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-0.01	-0.01	-0.04	-0.03	-0.02	-0.04
Debt / FCF Ratio	-0.02	-0.02	-0.04	-0.03	-0.02	-0.05
Quick Ratio	28.80	28.80	58.76	37.50	15.25	14.02
Current Ratio	28.89	28.89	59.01	37.72	15.56	14.28
Interest Coverage	-56.03	-56.03	-	-	-	-1082.00
Return on Equity (ROE)	-39.90%	-39.90%	-13.80%	-22.40%	-32.90%	-34.30%
Return on Assets (ROA)	-38.60%	-38.60%	-13.30%	-21.20%	-31.00%	-32.10%
Return on Capital (ROIC)	-23.00%	-23.00%	-19.60%	-25.26%	-37.60%	-20.81%
Return on Capital Employed (ROCE)	-21.48%	-21.48%	-14.34%	-23.66%	-37.57%	-20.75%
Earnings Yield	-22.06%	-12.34%	-21.79%	-29.06%	-62.37%	-26.05%
Earnings Yield	-22.06%	-12.34%	-21.79%	-29.06%	-62.37%	-26.05%
FCF Yield	-8.55%	-8.55%	-20.47%	-31.96%	-60.70%	-20.72%
Dividend Yield	99.80%	99.80%	0.00%	0.00%	0.00%	0.00%
Payout Ratio	-500.20%	-500.20%	0.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	-1297.57%	-1297.57%	-0.04%	-3.64%	-195.18%	-256.50%
Total Shareholder Return	-1197.77%	-1197.77%	-0.04%	-3.64%	-195.18%	-256.50%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).